HomeAbout

TL;DR CNBC


Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says - TL;DR CNBC

Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says

Publishing timestamp: 2020-09-09 16:18:03


Summary


Sentiment: NEGATIVE

Tickers: AZN-GB

Keywords:

Source: https://www.cnbc.com/2020/09/09/covid-19-vaccine-trial-participant-had-neurological-symptoms-astrazeneca-ceo-says.html


Developed by Leo Phan